Quang X. Pham, CEO and Chairman at Cadrenal Therapeutics, Inc. (CVKD), sold 8,865 shares at $13.99 ($124K) on 2025-08-27, disclosed to the SEC on 2025-08-29.
Scheduled sale ($124k) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.99 | 3,836 | $54K | 43.3% |
| 2 | $13.99 | 3,836 | $54K | 43.3% |
| 3 | $13.99 | 1,193 | $17K | 13.5% |
| Total | $13.99 avg | 8,865 | $124K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |